Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 26 Prostatic Neoplasms 24 Breast Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Sarcoma 12 Leukemia, Myeloid, Acute 12 Glioma 12 Lymphoma, Non-Hodgkin 10 Carcinoma, Hepatocellular 10 Wilms Tumor 9 Osteosarcoma 9 Colorectal Neoplasms 9 Rectal Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Neuroblastoma 8 Neoplasm Metastasis 8 Myelodysplastic Syndromes 8 Rhabdomyosarcoma 7 Rhabdoid Tumor 7 Pancreatic Neoplasms 7 Mouth Neoplasms 7 Medulloblastoma 7 Hepatoblastoma 7 Neuroectodermal Tumors, Primitive, Peripheral 6 Melanoma 6 Lymphoma 6 Histiocytosis, Langerhans-Cell 6 Head and Neck Neoplasms 6

Interventions

Cyclophosphamide 38 Paclitaxel 22 Epirubicin 21 Trastuzumab 20 Docetaxel 20 Doxorubicin 19 Carboplatin 15 Radiotherapy 13 Taxes 11 Filgrastim 11 Neoadjuvant Therapy 9 Bevacizumab 9 Fluorouracil 8 pembrolizumab 7 Tamoxifen 7 Albumin-Bound Paclitaxel 7 Capecitabine 6 pertuzumab 5 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Lapatinib 5 130-nm albumin-bound paclitaxel 5 pegfilgrastim 4 Granulocyte Colony-Stimulating Factor 4 Cisplatin 4 Chemotherapy, Adjuvant 4 Biopsy 4 tipifarnib 3 eribulin 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × X-Rays × Clear all

NCT07474090 2026-03-16

STEPS-BC

Wake Forest University Health Sciences

Phase NA Not yet recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡